Assistant Professor, Radiology, UCSF School of Medicine
Oncology
Dr. Robert A. Bok, MD
|
|
Give Review
Robert A. Bok practices Oncology. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. Dr. Robert A. Bok is a published doctor and has 59 publications published. The lastest was: 'Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.'
Publications
- Non-invasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance.
- Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites.
- A 2DRF pulse sequence for bolus tracking in hyperpolarized (13) C imaging.
- Dynamic hyperpolarized carbon-13 MR metabolic imaging of nonhuman primate brain.
- Simultaneous multiagent hyperpolarized (13) C perfusion imaging.
- Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate.
- Rapid sequential injections of hyperpolarized [1-¹³C]pyruvate in vivo using a sub-kelvin, multi-sample DNP polarizer.
- Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS.
- Frequency-specific SSFP for hyperpolarized (13)C metabolic imaging at 14.1 T.
- Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance spectroscopic imaging (MRSI).
- Perfusion and diffusion sensitive (13)C stimulated-echo MRSI for metabolic imaging of cancer.
- Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D (13) C magnetic resonance ...
- Use of hyperpolarized 1-(13)Cpyruvate and 2-(13)Cpyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the norma...
- A method for simultaneous echo planar imaging of hyperpolarized (13)C pyruvate and (13)C lactate.
- Investigating tumor perfusion and metabolism using multiple hyperpolarized (13)C compounds: HP001, pyruvate and urea.
- (13)C-Pyruvate Imaging Reveals Alterations in Glycolysis that Precede c-Myc-Induced Tumor Formation and Regression.
- Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype.
- Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
- Angiogenesis inhibition by minocycline.
- Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model.
- Bloodborne biomolecular markers in prostate cancer development and progression.
- Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer.
- Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015.
- Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor.
- Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
- The treatment of advanced prostate cancer with ketoconazole: safety issues.
- Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer an...
- Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.
- Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.
- Hepatic metastases: comparative study of diagnostic ultrasound, CT, nuclear scintigraphy and laboratory tests.
- Prospective comparative study of ultrasound, CT-scan, scintigraphy and laboratory tests to detect hepatic metastases.
- Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies.
- Current and potential applications of clinical 13C MR spectroscopy.
- Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience.
- In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate.
- Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.
- Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
- Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma.
- Multi-band frequency encoding method for metabolic imaging with hyperpolarized [1-(13)C]pyruvate.
- Detection of early response to temozolomide treatment in brain tumors using hyperpolarized (13) C MR metabolic imaging.
- Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models.
- Multi-channel metabolic imaging, with SENSE reconstruction, of hyperpolarized [1-(13)C] pyruvate in a live rat at 3.0 tesla on a clinical MR scanner.
- Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo.
- Metabolic imaging in the anesthetized rat brain using hyperpolarized [1-13C] pyruvate and [1-13C] ethyl pyruvate.
- Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI.
- Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.
- 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer.
- Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice.
- Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging.
- In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate.
- Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate.
- Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
- Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate.
- Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.
- [Complications after ERCP and their treatment].
- Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of pr...
- Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging.
- In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized [1-(13)C]alanine.
Schools
Johns Hopkins University School Of Medicine
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Minnesota at Fairview -
Johns Hopkins University School of Medicine
Hospital
-
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Garrett A. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. David R. Minor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charalambos I. Andreadis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Collin M. Blakely, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thierry M. Jahan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Moasser, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michelle E. Melisko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Small, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Frank H. Valone III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay A. Levy, MD |
|
|
Dr. Melisa L. Wong, MD
This Doctor is OpenDoctor Recommended.
|